SMAD4 Levels and Response to 5-Fluorouracil in Colorectal Cancer

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Cancer Research

• Publication date

  2005-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-05-0244PMID 16144935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SMAD4 as a Prognostic Marker in Colorectal Cancer

  2005cited by this paper
• Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directions

  2004cited by this paper
• Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells

  2004cited by this paper
• Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.

  2003cited by this paper
• c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis

  2003cited by this paper
• Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.

  2003cited by this paper
• Frequent loss of SMAD4/DPC4 protein in colorectal cancers

  2002cited by this paper
• TGF-β signaling in tumor suppression and cancer progression

  2001cited by this paper
• Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC).

  2001cited by this paper
• Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

  2001cited by this paper
• TGF-beta signaling in tumor suppression and cancer progression.

  2001cited by this paper
• Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies.

  2001cited by this paper
• Transcriptional control by the TGF‐β/Smad signaling system

  2000cited by this paper
• Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

  2000cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• Population-based molecular detection of hereditary nonpolyposis colorectal cancer.

  2000cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis

  1999cited by this paper
• Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

  1999cited by this paper
• Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.

  1999cited by this paper
• Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers

  1999cited by this paper
• SMAD genes in juvenile polyposis

  1999cited by this paper
• Smads and early developmental signaling by the TGFbeta superfamily.

  1998cited by this paper
• Mutations in the SMAD4/DPC4 gene in juvenile polyposis.

  1998cited by this paper
• Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.

  1998cited by this paper
• Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer.

  1998cited by this paper
• Chromosome 18q allelic loss and prognosis in stage II and III colon cancer

  1998cited by this paper
• Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.

  1998cited by this paper
• A breakpoint map of recurrent chromosomal rearrangements in human neoplasia

  1997cited by this paper
• The significance of allelic deletions and aneuploidy in colorectal carcinoma

  1997cited by this paper
• p53 point mutation and survival in colorectal cancer patients.

  1995cited by this paper
• Allelic loss of chromosome 18q and prognosis in colorectal cancer.

  1994cited by this paper
• Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate.

  1993cited by this paper
• TGF-beta expression in the human colon: differential immunostaining along crypt epithelium.

  1993cited by this paper
• Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer.

  1993cited by this paper
• Prognostic significance of K-ras mutations in colorectal carcinoma.

  1993cited by this paper
• Survival and acquired genetic alterations in colorectal cancer.

  1992cited by this paper
• Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

  1990cited by this paper
• Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

  1989cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation.

  1987cited by this paper

• Clinical impact of the methylation status of SMAD4 and AKR1B1 genes in a liquid biopsy sample as a prognostic marker for breast cancer

  2026cites this paper
• High Grade Colorectal Adenocarcinomas with SMAD4 Deficiency.

  2026cites this paper
• Rolling Circle Amplification Boosts Ultrasensitive Liquid Biopsy

  2025cites this paper
• Prognostic gene expression profile of colorectal cancer.

  2025cites this paper
• Paired mutation calling and spatial transcriptomics identify cellular neighbourhoods dictating the neoplastic outcome of colitis

  2025cites this paper
• Comprehensive genomic profiling of primary bladder mucinous adenocarcinoma, a rare genitourinary cancer: A case report

  2024cites this paper
• Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy

  2024cites this paper
• Determination of the frequency and distribution of APC, PIK3CA, and SMAD4 gene mutations in Ugandan patients with colorectal cancer

  2024cites this paper
• Myricetin can control metastasis and invasion by suppressing ATF2-related signaling pathway in Rapamycin-resistant HepG2 hepatocellular cancer cells

  2023cites this paper
• Deciphering the mechanism of Peptostreptococcus anaerobius-induced chemoresistance in colorectal cancer: the important roles of MDSC recruitment and EMT activation

  2023cites this paper
• Assessment of the Influence of 5-Fluorouracil on SMAD4 and TGFB1 Gene Expression, Apoptosis Induction and DNA Damage in Human Cell Lines

  2023cites this paper
• Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships

  2022cites this paper
• Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics

  2022cites this paper
• Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy

  2022cites this paper
• Mice with Dysfunctional TGF-β Signaling Develop Altered Intestinal Microbiome and Colorectal Cancer Resistant to 5FU.

  2021influential citation
• Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers

  2021cites this paper
• Assessment of the In uence of 5- uorouracil on the SMAD4 Gene Expression, Apoptosis induction and DNA Damage in the Human CACO-2 Cell Line

  2021cites this paper
• Association of SMAD4 loss with drug resistance in clinical cancer patients: A systematic meta-analysis

  2021cites this paper
• Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis

  2021cites this paper
• Theranostics Approaches to Gastric and Colon Cancer

  2020cites this paper
• Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer

  2020cites this paper
• Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan

  2020cites this paper
• Understanding Colorectal Cancer: The Basics

  2020cites this paper
• A SMAD4‐modulated gene profile predicts disease‐free survival in stage II and III colorectal cancer

  2020cites this paper
• Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial-mesenchymal transition

  2019cites this paper
• Adjuvant therapy with γ‐tocopherol‐induce apoptosis in HT‐29 colon cancer via cyclin‐dependent cell cycle arrest mechanism

  2019cites this paper
• The impact of somatic SMAD4 mutations in colorectal liver metastases.

  2019cites this paper
• Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma

  2019cites this paper
• SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.

  2018cites this paper
• Role of ZEB1 in Tumor Progression: Regulation of Cell Invasion and Senescence

  2017cites this paper
• Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer

  2017cites this paper
• Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer

  2017cites this paper
• Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer

  2017cites this paper
• Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer

  2017cites this paper
• Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer.

  2017cites this paper
• Loss of the EPH receptor B6 contributes to colorectal cancer metastasis

  2017cites this paper
• Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer

  2017cites this paper
• New insights into the colorectal carcinogenesis: from early precursor lesions to the role of aneuploidy

  2017cites this paper
• lncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-κB/TS Signaling in Colorectal Cancer

  2017cites this paper
• Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6 -treated patients

  2017cites this paper
• Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases

  2016cites this paper
• Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy

  2016cites this paper
• Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.

  2016cites this paper
• The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells

  2016cites this paper
• Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer

  2016cites this paper
• Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer*

  2016cites this paper
• Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer

  2016cites this paper
• Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer

  2015cites this paper
• Cell Cycle Checkpoint and DNA Damage Response Defects as Anticancer Targets: From Molecular Mechanisms to Therapeutic Opportunities

  2015cites this paper
• Overexpression of DHX32 contributes to the growth and metastasis of colorectal

  2015cites this paper
• A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer

  2015cites this paper
• Genetic mutations in human rectal cancers detected by targeted sequencing

  2015cites this paper
• Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer

  2015cites this paper
• Molecular biology of colorectal cancer in clinical practice

  2015cites this paper
• γ-Tocotrienol and 6-Gingerol in Combination Synergistically Induce Cytotoxicity and Apoptosis in HT-29 and SW837 Human Colorectal Cancer Cells

  2015influential citation
• Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer.

  2015cites this paper
• Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.

  2014cites this paper
• Molecular Alterations and Biomarkers in Colorectal Cancer

  2014cites this paper
• The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC

  2014cites this paper
• Meta-Analysis of the Prognostic Value of Smad4 Immunohistochemistry in Various Cancers

  2014cites this paper
• Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway

  2014cites this paper
• Molecular markers in radically resected colorectal cancer: from prognosis to prediction

  2013cites this paper
• Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis

  2013cites this paper
• Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma.

  2013cites this paper
• Personalized Management of Colorectal Cancer

  2013cites this paper
• Molecular Parameters for Prognostic and Predictive Assessment in Colorectal Cancer

  2013cites this paper
• Cancers of the Rectum and Anal Canal

  2013cites this paper
• TGF-ß Signaling Pathway and Colorectal Cancer

  2013cites this paper
• Long-term smoking mediated down-regulation of Smad3 induces resistance to carboplatin in non-small cell lung cancer.

  2012cites this paper
• International Evaluation of Research and Doctoral Training at the University of Helsinki 2005-2010: RC-Specific Evaluation of CSB - Cancer Systems Biology RC

  2012cites this paper
• Brain Metastases from Colorectal Cancer: Microenvironment and Molecular Mechanisms

  2012cites this paper
• Personalized medicine in colorectal cancer: the evidence so far

  2012cites this paper
• Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma.

  2012cites this paper
• Predictive and Prognostic Factors in Colorectal Cancer: A Personalized Approach

  2011cites this paper
• SMAD4 protein expression and cell proliferation in colorectal adenocarcinomas

  2011cites this paper
• Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group.

  2011cites this paper
• Therapeutics , Targets , and Chemical Biology Smad 4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer

  2011cites this paper
• Challenges in the management of stage II colon cancer.

  2011cites this paper
• Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma.

  2011cites this paper
• DNA copy number profiles correlate with outcome in colorectal cancer patients treated with fluoropyrimidine/antifolate-based regimens.

  2011cites this paper
• Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer

  2011cites this paper
• Molecular Genetic Pathology of Solid Tumors

  2011cites this paper
• Kolorektal kanser: Genetik ve moleküler biyoloji araştirmalari hasta tedavisine yeterince yansiyor mu? Colorectal cancer: are genetic and molecular biology researches reflected enough in the patient management?

  2011cites this paper
• Smad4 inactivation promotes malignancy and drug resistance of colon cancer.

  2011cites this paper
• Roles of VEGF-C and Smad4 in the Lymphangiogenesis, Lymphatic Metastasis, and Prognosis in Colon Cancer

  2011cites this paper
• Smad4 may help to identify a subset of colorectal cancer patients with early recurrence after curative therapy.

  2011cites this paper
• THE GENETICS OF COLORECTAL CANCER

  2010cites this paper
• Germline determinants of outcome and risk in colorectal cancer

  2010cites this paper
• The role of SMAD4 in early‐onset colorectal cancer

  2010cites this paper
• Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery

  2010cites this paper
• Molecular Prognostic Markers in Colon Cancer

  2010cites this paper
• Colorectal cancer molecular biology moves into clinical practice

  2010cites this paper
• Colorectal cancer

  2010cites this paper
• Strong Smad4 Expression Correlates with Poor Prognosis After Surgery in Patients with Hepatocellular Carcinoma

  2009cites this paper
• Colon Cancer Adjuvant Treatment Trial Context: a Feasibility Study on the PETACC3 Stage II and III Tissue Biomarker Development in a Multicentre Trial

  2009cites this paper
• Strong Smad4 Expression Correlates with Poor Prognosis After Surgery in Patients with Hepatocellular Carcinoma

  2009cites this paper
• Tissue Biomarker Development in a Multicentre Trial Context: a Feasibility Study on the PETACC3 Stage II and III Colon Cancer Adjuvant Treatment Trial

  2009cites this paper
• Genetic prognostic and predictive markers in colorectal cancer

  2009cites this paper
• Unregulated smooth-muscle myosin in human intestinal neoplasia

  2008cites this paper
• TGF-β has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell lines

  2008cites this paper